Related Experiment Video
Updated: Jun 12, 2025

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
Lipoprotein(a) and cardiovascular disease
Michael B Boffa1,2, Marlys L Koschinsky2,3
1Department of Biochemistry, University of Western Ontario, London, Ontario, Canada.
High lipoprotein(a) (Lp(a)) levels are a major risk for cardiovascular diseases. This review covers Lp(a) biochemistry, disease links, concentration factors, and emerging Lp(a)-lowering drugs.
Area of Science:
- Cardiovascular Medicine
- Biochemistry
- Pharmacology
Background:
- Elevated lipoprotein(a) (Lp(a)) is a significant, independent risk factor for atherosclerotic cardiovascular disease and calcific aortic valve disease.
- Lp(a) comprises a low-density lipoprotein-like particle with an attached apolipoprotein(a) (apo(a)) glycoprotein.
- Despite advanced clinical development of Lp(a)-lowering therapies, key questions about Lp(a) metabolism and pathogenicity persist.
Purpose of the Study:
- To review the biochemical characteristics of Lp(a) and apo(a).
- To elucidate the mechanisms underlying Lp(a)'s disease-causing potential.
- To discuss factors influencing plasma Lp(a) concentrations and the action of Lp(a)-lowering drugs.
Main Methods:
- Literature review of biochemical and clinical studies on Lp(a).
- Analysis of factors affecting Lp(a) biosynthesis and catabolism.
- Examination of the mechanisms of action for novel Lp(a)-lowering therapeutics.
Main Results:
- Lp(a) and apo(a) possess distinct biochemical features contributing to cardiovascular risk.
- Genetic and physiological factors significantly influence plasma Lp(a) levels.
- Emerging drugs demonstrate potent Lp(a) reduction in clinical trials.
Conclusions:
- Understanding Lp(a) biochemistry is crucial for its pathogenic role in cardiovascular diseases.
- Further research into Lp(a) metabolism and pathogenicity is warranted.
- Novel Lp(a)-lowering therapies hold promise for cardiovascular risk reduction.
Related Concept Videos
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Cholesterol: Significance and Regulation
Considering cholesterol and...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

